Posts
State Strategies to Increase COVID-19 Vaccination Rates in Children
/in COVID-19 Relief and Recovery Resource Center Blogs, Featured News Home Back to School, COVID-19, Relief and Recovery, Vaccines /by Michelle Fiscus and Rebecca CooperCOVID-19 vaccines have been available for children ages 5-11 since October 29, 2021. As of March 16, 2022, the Centers for Disease Control and Prevention (CDC) reports that just one-third (33%) of children in this age group have received their first vaccine dose, with vaccination rates varying widely by state. Just twenty-six percent of 5–11-year-olds have been fully vaccinated.
The ten states with the highest fully vaccinated rates among children ages 5-11 years (Vermont, Massachusetts, Rhode Island, Hawaii, Maine, Maryland, Connecticut, Virginia, Minnesota, and Illinois) have adopted creative approaches to promoting COVID-19 vaccination.
This blog highlights several of these approaches, which states may consider adopting when encouraging parents to get their children vaccinated against COVID-19 and other vaccine-preventable diseases. These strategies may be extended to vaccination activities for 6-month to 4-year-olds once COVID-19 vaccines receive emergency use authorization for this age group from the U.S. Food and Drug Administration.
Incentives
Many states have offered incentives to encourage COVID-19 vaccination. These incentives range from college scholarships to free food, with mixed results when evaluated for impact on vaccination uptake. A randomized clinical trial in Sweden in 2021 demonstrated that monetary incentives increased vaccination rates by approximately 4 percent. Other research has suggested incentives are most effective when three criteria are met: receipt of the incentive is certain, incentives are delivered immediately, and the recipients value the incentives. Several states in the top 10 for vaccine coverage offered incentives for vaccinating children ages 5-11, including:
- Vermont created the School Vaccine Incentive Program in December 2021, which provides monetary awards to schools achieving an 85 percent student vaccination rate. Schools are awarded $15 per vaccinated student with a minimum award of $2000 and a maximum award of $10,000. Schools achieving at least 90 percent student vaccination rate can apply for an additional 50 percent of the initial award, up to a maximum award of $15,000. The state is using federal emergency funds to support the program, which runs through April 1, 2022.
- Minnesota launched its “Kids Deserve a Shot!” campaign, providing families with a $200 Visa gift card if their 5-11-year-old child received both doses of a COVID-19 vaccine between January 1 and February 28, 2022. More than 22,000 children registered to receive a gift card as a result of this program. On March 1st, the Governor announced that any Minnesota parent or guardian whose 5 to 11-year-old had ever received both doses of COVID-19 vaccine by April 11, 2022, can enter to win one of five $100,000 Minnesota College Scholarships. This strategy was modeled after the state’s successful program to vaccinate children ages 12-17.
- Six months after 12-17-year-olds became eligible, the state launched the program to help drive up vaccination in the youth population, which had the lowest vaccination rate at the time. Within one week of the start of the campaign, first dose vaccinations increased nearly 40%. The state offered a $200 Visa gift card for 12-17-year-olds who started and completed their vaccine series within a six-week window, and five drawings of $100,000 Minnesota college scholarships for any Minnesotan 12-17 years old with a complete vaccine series.
School-located Vaccination Clinics
States play an important role in the success of school-based COVID-19 vaccination clinics. States can support schools with coordination of efforts, financial support, and media outreach in addition to providing vaccination supplies, personal protective equipment, and personnel to support these activities.
- Virginia recently published a playbook to support school-based vaccination events. “Vaccination of the School-Age Population in a School Setting and in the Community: Playbook to Support Vaccination Events” was created in partnership with the state’s immunization coalition, Vaccinate VA, and provides information for planning and conducting school-located COVID-19 vaccination clinics for the 5- to 11-year-old population.
- Connecticut published its “#Vax2SchoolCT” toolkit, which outlined step-by-step logistical considerations and recommendations for promotion and outreach. The toolkit provides a letter template for communications to students and families as well as information on the state’s “Vaccine+ Program,” which connects families to resources such as water and heating assistance.
- In Hawaii, schools were the main staging ground for administering COVID-19 vaccinations to children ages 5-11, with over 100 public, private, and charter schools holding vaccination clinics.
- Illinois organized 756 elementary school districts to offer vaccination clinics for students ages 5-11 on school grounds. Their mobile vaccination teams conducted more than 870 school and youth events when vaccines became available for 12-17-year-old students.
Parent-friendly Websites
States can provide public-facing information that is easy to access and navigate and that makes choosing to get vaccinated the easy choice. Several states have webpages dedicated to COVID-19 vaccinations for children.
- Vermont’s dedicated website for pediatric COVID-19 vaccines, “Just for Them!”, provides an online consent form and pre-vaccination checklist translated in many languages. Twenty-five percent of Vermont’s 5–11-year-old population registered to receive a vaccine within eight hours of opening registration to the public.
- Minnesota posted their “COVID-19 Vaccines and Kids: What Pediatricians Are Saying,” video to the state’s website, providing information to parents who may be hesitant about getting their children vaccinated.
- Massachusetts has a dedicated website for COVID-19 vaccines for 5-11-year-old children that includes a downloadable consent form, answers to frequently asked questions, and includes a chatbot that can answer COVID-19 vaccine-related questions in real time.
Partnerships
States can partner with organizations such as their state chapter of the American Academy of Pediatrics, state and local immunization coalitions, and hospitals to help build confidence in COVID-19 vaccines and improve access to vaccination for children. For example:
- Vermont and the Vermont Chapter of the American Academy of Pediatrics partnered to provide Facebook live “Chapter Family Forum” events featuring Vermont pediatricians who discussed the importance of vaccinating children against COVID-19.
- Rhode Island and Lifespan’s Hasbro’s Children’s Hospital partnered to provide hospital-based COVID-19 vaccination clinics for children ages 5 to 11.
- Minnesota partnered with the Mall of America to vaccinate children. The Mall of America clinic had the capacity to vaccinate 1,500 children per day.
- Massachusetts partnered with museums such as the Discovery Museum in Action, Boston’s Museum of Science, and the EcoTarium Museum to offer age-specific vaccination clinics for younger children.
- Illinois announced that the Illinois Department of Public Health had “reached out to every pediatrician in the state to enroll them in the vaccine distribution program” and then called on parents to call their pediatricians and make sure they had enrolled and ordered doses. The state enrolled more than 2,200 locations to provide vaccinations to 5-11-year-olds, including more than 700 medical practices, more than 700 pharmacies, 100 urgent care centers, 112 local health departments and public health clinics, 270 federally qualified health centers, more than 200 hospitals, and dozens of rural health clinics.
Media
Federal funding has provided states with unprecedented opportunities to create media messages promoting COVID-19 vaccinations for children. States can play a vital role in building vaccine confidence and promoting vaccination for children through media. Examples of such messages include:
- Vermont partnered with Vermont Public Radio’s “But Why: Podcast for Curious Kids” to explain the importance of kids getting COVID-19 vaccines and hear from kids who took part in COVID-19 vaccine trials.
- Maine announced a contest for children ages 5 to 17 to create a short video that explains the benefits of getting the COVID-19 vaccine or the risk of not getting vaccinated. The first place winner was awarded $50,000 for their school, with $25,000 going to second place and $10,000 to third place. Schools can use the prize money to supplement school meals with healthy treats; purchase playground, classroom, gym, sports, or music equipment; enhance a special school activity; or support a school field trip for all students.
- Maryland partnered with the Maryland Chapter of the American Academy of Pediatrics to create a public service announcement featuring pediatric health care providers from around the state who encourage parents to get their children vaccinated against COVID-19.
- Illinois, in partnership with the Illinois Chapter of the American Academy of Pediatrics, created a COVID-19 Pediatric Vaccine Social Media Toolkit to provide credible, informative, and diverse social media messaging to promote COVID-19 vaccination for children ages 5 years and older. The toolkit included pediatric vaccination flyers, social media digital resources, and videos, including a video from the director of the Illinois Department of Public Health, Dr. Ngozi Ezike, who is a board-certified internist and pediatrician and the first Black woman appointed to lead the agency.
With FDA emergency use authorization of COVID-19 vaccines on the horizon for children ages 6 months to 4 years-old, states will need to continue to find new and innovative approaches to encourage parents to vaccinate their children and to ensure vaccinations are readily accessible.
Strategies to Increase COVID-19 Vaccination Rates in Medicaid Enrollees: Considerations for State Leaders
/in COVID-19 Relief and Recovery Resource Center Featured News Home, Reports COVID-19, Relief and Recovery, Vaccines /by NASHP StaffState Plans for Vaccinating their Populations against COVID-19
/in COVID-19 State Action Center, Policy Charts, Featured News Home, Maps COVID-19, Health Equity, Immunization, Maternal, Child, and Adolescent Health, Population Health, Social Determinants of Health, Vaccines /by Rebecca Cooper, Ariella Levisohn and Jill RosenthalJohnson & Johnson COVID-19 Vaccine Helps States Boost Supply, But Messaging Remains Critical
/in COVID-19 State Action Center Blogs, Featured News Home COVID-19, Health Equity, Housing and Health, Population Health, Social Determinants of Health, Vaccines /by Ariella LevisohnThe US Food and Drug Administration’s (FDA) recent approval of the one-dose Johnson & Johnson (J&J) vaccine, which is easier to store and transport than others and reportedly causes fewer side effects, offers opportunities for states to improve vaccination outreach.
At a time when supply remains one of the largest barriers to vaccine administration, the new J&J vaccine helps boosts supply and allows more people to be vaccinated. However, efforts to distribute the newest vaccine have been complicated by mixed messaging around its efficacy. States, with federal guidance, are working to emphasize the benefits of the J&J vaccine and the importance of getting vaccinated as soon as any vaccine is available.
Background
In clinical trials, the J&J vaccine had a 72 percent efficacy overall in the United States, with an 85 percent efficacy against severe COVID-19 infection. While there is some public concern that the J&J vaccine has a lower efficacy than Pfizer and Moderna’s, experts are stressing two facts:
- The (J&J) vaccine has a high efficacy against severe disease and is just as effective at preventing hospitalization and mortality as the older vaccines. Those who do get COVID-19 after J&J vaccination are likely to only experience only mild symptoms.
- Unlike the Moderna and Pfizer vaccines approved in December, J&J was tested in Brazil and South Africa in the presence of the new 1.351 variant. It proved to be highly effective at preventing infection and severe disease from these COVID-19 variants.
J&J Vaccine Advantages
In addition to its success against virus variants, the J&J vaccine has a number of different characteristics that make it easier to transport, store, and administer than the Moderna and Pfizer vaccines.
First and foremost, the vaccine requires one dose rather than two. State officials have shared that scheduling second doses, reminding patients to come in for their second dose, and following up when individuals miss their appointments have been significant challenges in their vaccine rollout. The one-dose J&J vaccine eliminates this issue.
Additionally, the J&J dose is easier to store and can be kept in a regular refrigerator for up to three months. This makes it possible that more and different types of health care providers, such as those working in rural health centers or with communities that have limited access to health care, can keep the vaccine in their facilities so their patients can receive the COVID-19 vaccine from providers whom they view as trusted sources.
Many J&J recipients also report fewer side effects from the vaccine, making the vaccine ideal for individuals who cannot afford to miss a day of work because of severe side effects, or who might not be connected to a health care professional who can help treat symptoms if needed.
Importance of Messaging
Throughout the pandemic, federal and state governments and public health leaders have struggled to find a balance between managing public expectations and encouraging measures that prevent the spread of COVID-19. The introduction of the J&J vaccine has again highlighted the importance of crafting messages for the public to counter any misinformation about its efficacy.
After concerns began arising about the efficacy of the J&J vaccine, the Centers for Disease Control and Prevention (CDC) recommended that jurisdictions use the following language when promoting the J&J vaccine, “All the available vaccines have been proven effective at preventing serious illness, hospitalization, and death from COVID-19 disease.” The CDC also encourages individuals to get the first vaccine available to them. States are beginning to craft their own messages to reach their residents.
Before opening up new vaccine appointments, the Washington, DC Department of Health sent an email using the CDC’s language to all residents who signed up for vaccine alerts. The email noted that individuals will be able to see which vaccine is being administered at each site before choosing an appointment, but emphasized that all vaccines are effective at preventing “serious illness, hospitalization, and death from COVID-19,” and that residents are “highly encouraged to take the first vaccine available to them.” All appointments were booked within minutes, suggesting that Washington, DC residents were willing to take whichever vaccine was available.
In Iowa, Gov. Kim Reynolds received the J&J vaccine during a news conference to help promote the vaccine and emphasized her trust in the vaccine before her constituents. She also addressed concerns about the J&J vaccine’s efficacy, noting, “This information is misleading, and quite frankly, it’s irresponsible to position any vaccine as a less desirable option when it’s undergone the same rigorous clinical trials to test the safety and efficacy and has received approval by the FDA and the CDC.”
Gov. Jay Inslee of Washington State also issued a statement about the J&J vaccine in a recent interview, where he acknowledged the lower efficacy rates in clinical trials, but also praised the advantages of this vaccine compared to others. “It’s going to save your life, which we think is a pretty high value. It has a downside of slightly lower efficacy to prevent you from getting a headache — but you only have to have one shot instead of two,” he explained.
Federal and state governments are also navigating the tension between the value of setting aside allocations of the J&J vaccine for individuals who face more barriers to getting two doses, and the danger of targeting a vaccine that some constituencies believe is less valuable to more vulnerable and historically marginalized populations.
Conclusion
Supply remains a key concern in state and federal vaccination efforts. However, President Biden’s announcement that the United States will have enough supply to vaccinate the entire adult population by May, in part due to J&J’s partnership with Merck to ramp up manufacturing, creates even more pressure to ensure that public health messaging effectively promotes the benefits of all vaccines equally.
In the meantime, the J&J vaccine arrives as many states are broadening their vaccine eligibility guidelines. According to National Academy for State Health Policy analysis, 35 states are now vaccinating individuals age 65 and older and 43 states are vaccinating teachers and/or childcare providers. During the first week of March, 11 states began vaccinating teachers, and four states expanded eligibility to individuals age 50 and older. This new vaccine can help ensure that newly eligible individuals can be vaccinated promptly, bringing the nation closer to herd immunity.
Acknowledgements: This blog is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) as part of a financial assistance award totaling $250,000 with 100 percent funded by CDC/HHS. The contents are those of the author and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS or the US government. CDC General Terms and Conditions for Non-research Awards, Revised: February 2021.
State Strategies for Vaccinating Individuals Experiencing Homelessness against COVID-19
/in COVID-19 State Action Center Blogs, Featured News Home COVID-19, Health Equity, Housing and Health, Population Health, Social Determinants of Health, Vaccines /by Ariella LevisohnIndividuals experiencing homelessness often face more barriers to obtaining a COVID-19 vaccination than others. As more vaccines become available and supplies increase, new and emerging best practices for vaccinating individuals in homeless shelters may help states more efficiently vaccinate other hard-to-reach or medically vulnerable populations, such as those living in rural areas or congregate settings.
Introduction
The Centers for Disease Control and Prevention (CDC) classifies individuals experiencing homelessness as a high-risk population. Homeless shelters are congregate settings, which can facilitate the rapid spread of COVID-19 infection, and many individuals who are homeless also suffer from other medical conditions that put them at high risk of COVID-19-related complications. While some states group all individuals residing in congregate settings into one vaccination priority category, others specifically identify individuals in homeless shelters as a priority population. As a result, these individuals’ vaccination eligibility differs between states.
According to a recent analysis by the National Academy for State Health Policy (NASHP), 34 states explicitly include residents of homeless shelters as a priority population. A few states, including Wyoming and Washington, DC, explicitly prioritize “individuals experiencing homelessness.” Washington State lists “people experiencing homelessness that access services or live in congregate settings (e.g., shelters, temporary housing)” in its latest vaccine prioritization plan.
Every state has changed its eligibility criteria and prioritization guidelines as the CDC and the Department of Health and Human Services (HHS) have issued new recommendations based on the constantly changing vaccine rollout picture. Some states have identified these individuals in their plans and moved this population up in priority, while others have instead reprioritized other populations. For example, Wyoming recently moved individuals experiencing homelessness up in their prioritization. Arizona elevated individuals with high-risk medical conditions living in shelters as well all adults in congregate settings. Wisconsin added individuals in homeless shelters and in transitional housing to a priority phase of the state plan after previously not prioritizing this population. As of March 1, 2021, 15 states were vaccinating individuals experiencing homelessness.
Challenges
In addition to the general vaccine distribution challenges states are facing – such as limited vaccine supplies, tracking data on doses administered, personnel shortages, and vaccine hesitancy – vaccinating individuals experiencing homelessness has its own difficulties:
- Conflicting priorities: On top of concerns about vaccine safety and mistrust of the health care system, many individuals experiencing homelessness are hesitant to receive the vaccine because they see other challenges – such as housing status, food insecurity, and financial instability – as more immediate concerns.
- Transportation barriers: Many individuals experiencing homelessness face transportation barriers that prevent them from traveling to mass vaccination clinics.
- Tracking second doses: For those who receive the Moderna or Pfizer vaccines, the state must figure out how to track where individuals are to ensure they receive their second dose and are fully immunized. It is particularly challenging for states to track second doses for individuals who are only in a shelter temporarily, or primarily live on the street.
- Limited technology: Many people living on the street or in shelters do not have internet access, and therefore cannot sign up for vaccine appointments through state websites.
- Connection to health care providers: Individuals experiencing homelessness are less likely to be connected to health care providers or health care systems, making it more difficult to get an appointment or find out when they are eligible.
- Vaccine Storage: In order to reach individuals living on the street, providers need to be able to transport doses to encampments and other areas where individuals frequently live. However, the vaccines’ refrigerated storage requirements make bringing doses directly to individuals on the street difficult.
States are working diligently to determine strategies and best practices for vaccinating individuals experiencing homelessness. As supply increases and becomes less of a barrier to vaccine administration, it is critical to address access-related barriers that may prevent some individuals from receiving the vaccine and exacerbate existing health disparities.
State Approaches
As with most decisions related to vaccine distribution, eligibility criteria for priority populations has been left to states. Of the limited states already vaccinating individuals experiencing homelessness, many have turned to private organizations to aid in vaccinating individuals experiencing homelessness. In these cases, the state distributes doses to nonprofit organizations that work to address homelessness or provide health care to the homeless, and these organizations take the lead in organizing clinics and administering doses.
Since early February 2021, the Washington, DC Department of Human Services has partnered with Unity Health Care, the District’s largest network of federally qualified heath centers, to hold vaccination clinics at homeless shelters. Unity Health Care is also trying to vaccinate individuals living on the street when possible through case managers and outreach teams. Washington, DC is eliminating certain barriers to vaccination for individuals experiencing homelessness, including waiving the requirement to provide an ID at appointments, giving individuals waterproof wallets in which to keep their vaccination cards, and providing free transportation to clinics located at some homeless shelters.
In Connecticut, the state and local health departments are coordinating vaccination efforts in congregate facilities – including homeless shelters – affiliated with the state, and partnering with private nonprofits to actually administer the doses. Some hospitals and cities in Connecticut are also using mobile vaccination clinics to reach individuals in congregate settings.
In Massachusetts, the nonprofit Boston Health Care for the Homeless Program (BHCHP) is playing a crucial role in vaccinating individuals experiencing homelessness in the Boston area. BHCHP is leveraging the City of Boston’s Homeless Management Information System (HMIS) – which connects to their electronic health records system Epic – in conjunction with the state’s Immunization Information System (IIS) to track first doses administered and to send out second dose text reminders. Shelter can access these reminders and provide outreach to patients to make sure they get their second doses. BHCHP is also using their grant funding and their own funding to incentivize vaccinations among the populations they serve, including providing gift cards, clothing, and snacks and combatting vaccine hesitancy by training individuals experiencing homelessness to provide peer counseling. To date, the nonprofit reports it has been successful at ensuring individuals return for their second doses. BHCHP also announced plans to start vaccinating individuals living on the street. They hope to use a van to store doses while they drive to areas where individuals on the street often live.
As states try to simultaneously provide information about vaccination clinic locations, recruit and train personnel to administer vaccines, monitor individuals after vaccination, and plan mass clinics, nonprofits are a valuable resource for reaching specific populations. Many private organizations, especially those already working to address homelessness and housing insecurity, have existing relationships with individuals experiencing homelessness and are already trusted service providers. They have been providing outreach to these communities throughout the pandemic and are poised to take on some of the work of vaccinating individuals experiencing homelessness.
Looking Forward
Because demand for the vaccine still exceeds supply, states are challenged to prioritize their populations. States have to make tough decisions that promote health equity, decrease infection rates, promote vaccine efficiency, and prevent deaths. States that have not yet started vaccinating individuals experiencing homelessness can learn from others that are already vaccinating this population so that they can more effectively reach those living in shelters and on the street.
As states – and their partnering nonprofits – pilot strategies like mobile vaccine clinics and offer incentive payments and peer counseling in order to reach individuals experiencing homelessness and encourage vaccinations, these and similar initiatives can inform efforts to vaccinate other hard-to-reach populations.
Acknowledgements: This blog is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) as part of a financial assistance award totaling $250,000 with 100 percent funded by CDC/HHS. The contents are those of the author and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS or the US government. CDC General Terms and Conditions for Non-research Awards, Revised: February 2021.
2021 State of the States: Amid the Pandemic, Governors Tackle Health, Social, and Economic Issues
/in Policy Charts, Maps Chronic Disease Prevention and Management, Consumer Affordability, COVID-19, Eligibility and Enrollment, Equity, Health Coverage and Access, Health Equity, Health System Costs, Housing and Health, Immunization, Maternal, Child, and Adolescent Health, Population Health, Social Determinants of Health /by NASHP StaffStates Identify and Address COVID-19 Vaccine Disparities through Targeted Rollout and Outreach
/in COVID-19 State Action Center Blogs, Featured News Home COVID-19, Health Equity, Population Health, Social Determinants of Health, Vaccines /by Rebecca Cooper, Ariella Levisohn and Jill RosenthalAs states rapidly work to get COVID-19 vaccines into arms as quickly as possible as viral variants spread, state officials know vaccine rollout plans must focus on equitable distribution to communities of color, especially Black and Latinx communities that have experienced disproportionately high infection rates, hospitalizations, and deaths. However, early data suggests that these populations are receiving vaccines at lower rates than White Americans.
As President Biden highlights his administration’s commitment to equity, officials from a cross section of states told the National Academy for State Health Policy (NASHP) how they are working to simultaneously build and strengthen systems to track and address disparities in COVID-19 vaccine administration.
The Biden Administration’s National Strategy for the COVID-19 Response emphasizes equity in vaccine distribution to “protect those most at risk and advance equity, including across racial/ethnic and rural/urban lines.” This includes increasing data collection and reporting for high-risk groups, supporting communities most at risk of COVID-19, and ensuring equitable access to critical COVID-19 personal protective equipment, tests, therapies, and vaccines. These steps help achieve equity by identifying underserved communities, sending them extra vaccine supplies, improving public trust in the vaccine, and ensuring individuals are able to get vaccinated.
Recently, the Biden Administration announced it will begin shipping an additional 1 million vaccine doses each week to thousands of pharmacies across the country in an effort to improve equity and increase access to the vaccine.
Preliminary data highlights vaccine disparities:
As of Feb. 8, 2021, less than 3 percent of the US population had been vaccinated with both doses to date. Though data is limited and race and ethnicity are widely underreported, preliminary data does show racial disparities.
The US Centers for Disease Control and Prevention’s Feb. 1, 2021 Morbidity and Mortality Weekly Report noted that to date 60.4 percent of vaccine recipients were White and 39.6 percent were people of color.
However, only 50 percent of the 6.7 million doses administered through Jan. 14, 2021 documented the race and ethnicity data of vaccine recipients.
The available data highlights disparities in communities of color:
• 4 percent of vaccine recipients were Black (though Black people make up 12.2 percent of the population); and
• 5 percent self-reported as Hispanic/Latino (who make up 18.5 percent of the US population).
Pharmacies will be a critical venues for vaccine access, and this pharmacy distribution program is expected to build that capacity as the US Centers for Disease Control and Prevention (CDC) and state health directors work together to identity areas of need and ship vaccines to pharmacies in those areas, especially in the early days of the program when distribution is still curtailed by limited vaccine supplies. State officials told NASHP that the selection of pharmacies will be based on their ability to both reach the most vulnerable populations and also align with states’ current distribution phases and priority populations in their vaccination plans.
Pandemic responses have shown that federal leadership is key to success. The following examples highlight how state efforts to collect and analyze trends in race and ethnicity data, supported by strong directives from the White House and a centralized federal task force, can guide decision making and promote the implementation of concrete strategies to reduce disparities.
For more information on which states are tracking vaccination data by race and ethnicity, explore NASHP’s interactive map.
Tracking and Reporting Race and Ethnicity Data
One of the first steps to ensure equitable access to vaccines is having the data to determine where disparities exist. Forty-eight states and Washington, DC currently collect and share varying levels of vaccine data in publicly available data dashboards. Of these, 26 states and Washington, DC publicly display race and ethnicity data for individuals who have received their vaccines. States report the data slightly differently – which can result in different conclusions about their efforts. They are reporting either:
- Total number of individuals vaccinated by race and ethnicity (for example, Florida and Pennsylvania);
- Percentage of total individuals of each race or ethnicity in the state who have been vaccinated (North Dakota); or
- Percent of total doses that have gone to individuals by each race and ethnicity (Indiana and North Carolina).
While these state trackers provide some insight into who is getting vaccinated, there are limitations in their data – a large percentage of race and ethnicity data is either missing or not reported. Nationwide, race and ethnicity data is missing for nearly half of those vaccinated, compared to age and gender data, which is reported 99.9 and 97 percent of the time, respectively. Even in states that collect and publicly report this data, some report over 50 percent of doses with “unknown” race and ethnicity. Providers will report “unknown” in the race and ethnicity fields either because the providers do not ask for the data, or because the recipients do not provide it. It is unclear why individuals are declining to provide their race and ethnicity, but some experts believe that some concerns may stem from a fear that their demographic data could be misused. For example, immigrants are concerned that getting the vaccine – or providing their data – may negatively affect their immigration status. However, the CDC said that vaccine data cannot be used for immigration enforcement, and that getting the COVID-19 vaccine will not be considered as part of the public charge inadmissibility rule.
Many states are working to improve their data collection and reporting. Some, such as Alabama, are collecting race and ethnicity data but have not yet made it public because it is incomplete. These states are working to collect complete and accurate data before publishing it. Most states that are reporting race and ethnicity data publicly do not require providers to include that information, citing a lack of express permission from the patient or concern that requirements might prevent providers from reporting vaccine doses at all.
Other states are imposing requirements to improve data. In North Carolina, Department of Health and Human Services Secretary Mandy Cohen pushed to make race and ethnicity a required field in the state’s COVID-19 vaccine registry. According to state officials, North Carolina emphasizes equity as a core value and conducts outreach and training with providers to emphasize the importance of race and ethnicity data. The availability of the data has enabled outreach strategies, such as partnerships with faith leaders.
While requiring providers to upload race and ethnicity data can add to administrative and logistical challenges, collecting the data is critical to ensuring that vaccine outreach and administration are targeted to the communities most in need. If large percentages of race and ethnicity data are missing, ensuring equity in distribution becomes much more difficult.
State Strategies to Reduce Disparities in Vaccination
Tracking disparities by identifying gaps in data is only the first step. In response to early data that showed disparities, states are taking action to address inequity by scheduling clinics in high-need areas, facilitating vaccination in high-priority zip codes, and tailoring communications to address vaccine hesitancy. President Biden’s plan to add to states’ allotments by sending vaccines directly to local pharmacies beginning Feb. 11, 2021 will also aid in the goal of an equitable distribution. Pharmacy partners were selected in part based on their ability to reach socially vulnerable populations, and the program will follow each state’s current eligibility requirements to ensure individuals, especially those in high-need areas, have access to the vaccine. States are also currently working to reduce disparities by using strategies to increase access to, and comfort level with, the vaccine.
Many states are using the CDC’s Social Vulnerability Index (SVI) to identify areas of high need where vaccine distribution efforts should be targeted. The SVI is a CDC tool that uses US census variables – including socioeconomic status, transportation access, housing status, and language – to rank areas in order to help public health officials prepare for and respond to emergency events. A high ranking indicates that an area may need more support for their emergency response – in this case vaccination distribution and administration.
Locating Clinics in High-Need Areas
Delivering vaccines to underserved communities is key and the new Federal Pharmacy Program helps address this goal. States and local health departments can use preliminary data to identify counties or jurisdictions with disparities and low rates of vaccination uptake to use to target their vaccination efforts.
Rick Palacio, the cochair of Colorado’s COVID-19 Vaccine Equity Taskforce, announced that one of the state’s goals is to hold pop-up vaccination clinics in half of the state’s top 50 census tracts containing low-density, low-income communities. Officials emphasized the importance of using data to determine under-vaccinated areas and tailor communication strategies to reach those residents. The state kicked off this plan by vaccinating more than 10,000 seniors at a mass vaccination event in Denver and plans to expand the initiative as it receives more doses.
Other examples of state efforts to identify and reach underserved areas include:
- Rhode Island is using its hospitalization, death, and case data to target vaccine distribution by geography. Vaccines will be available in community clinics, pharmacies, and housing sites in communities that have been identified as high risk.
- Illinois has had success by holding events scheduled by local health departments that reached out to discreet, hard-to-reach communities and invited them to register for a vaccine appointments.
- Connecticut is closely tracking vaccine rollout in localities that rank high on the social vulnerability index.
- After Washington, DC opened its vaccine registration portal to all individuals over the age of 65, data quickly showed that an outsized proportion of appointments was going to wealthier White residents. In response, health officials made more appointments available for residents in parts of the city that were currently securing the fewest vaccine appointments. The city also started making appointments for residents in these high-priority zip codes available a day before other eligible residents could register.
- North Carolina has partnered with faith leaders to ensure communities of color and underserved communities have access to vaccinations at the state’s mass vaccination clinics, including releasing appointments to Black and Latinx church attendees before opening up registration to the general public.
States can also reduce transportation barriers to increase vaccination uptake and ensure transportation will not be a barrier for targeted populations to access the vaccine. North Carolina’s mass vaccination clinic location was chosen for its proximity to public transportation.
The Tennessee Department of Health (TDH) is expanding access to the COVID-19 vaccine by focusing on increasing vaccinations in rural and underserved areas. TDH partnered with pharmacies and community health clinics to add over 100 vaccination sites across the state, focusing on “hard-to-reach” areas, as identified in the state’s vaccination plan. Tennessee’s state plan indicated that 5 percent of the state’s allocation of COVID-19 vaccines are earmarked for use in targeted areas with vulnerable populations.
Additionally, at a February US House Energy and Commerce Oversight and Investigations Subcommittee hearing, Louisiana state officials cited a plan to create community mobile strike teams that will travel to areas that rank high on the social vulnerability index to administer vaccines. The strike teams will be staffed by the National Guard and funded by the Federal Emergency Management Administration, which reimburses states for 100 percent of costs associated with the National Guard’s COVID-19 relief efforts. A state official in Michigan also noted at this hearing that the increase in doses from the federal government will help advance equity, because those extra doses can be distributed directly to underserved areas and minority populations.
Tailoring Communication Strategies to Address Vaccine Hesitancy
While reporting and tracking vaccination data and removing logistical barriers are important strategies for identifying pockets of need, they alone are not sufficient to reduce disparities. A history of racism in the health care system has led to distrust by communities of color. Though the share of adults planning to get the COVID-19 vaccine has increased over the year, according to recent surveys White adults (53 percent) remain more likely than Black (35 percent) and Latinx (42 percent) individuals to want to be vaccinated as soon as possible. A survey last fall found that less than 20 percent of Black Americans trusted vaccine safety and efficacy. The survey also indicated that the best messengers to support vaccination in these communities are those living in their own communities, or their health care providers.
State officials and several members of the federal Advisory Committee on Immunization Practices (ACIP) mentioned that the desire to vaccinate quickly must be balanced with the need to reach vulnerable communities. State officials note that balancing speed and equity is one of the biggest challenges they face. Community input builds trust and assists in building effective and acceptable strategies. For example, Tennessee has an African American Health Care Clinician Workgroup, with working members from the NAACP, the Black Nursing Society, and other Black organizations, who are disseminating messaging on the importance of vaccinations and will ultimately help vaccinate Black communities. The Colorado Department of Health and Environment has released commercials in English and Spanish featuring Colorado health care workers who are people of color, promoting the message that vaccines are safe. West Virginia is funding faith-based community members and people of color to administer COVID-19 vaccines directly to communities of color, ascribing to the principle that having trusted, local figures helping with distribution will improve those communities’ confidence in the vaccine.
Conclusion
Federal and state governments are working to vaccinate residents as quickly as possible, while also working to ensure doses are equitably distributed. In light of reports of disparities in vaccination rates and in vaccination access among people of color and in rural communities, the Biden Administration is acting on its promise to ensure an equitable distribution, including their new strategy to ship extra doses to pharmacies in hard to reach areas. While distribution strategies vary across states and are continually tweaked to improve efficacy and equity, the emerging best practices:
- Use data to track and identify under-vaccinated areas and populations;
- Set up additional clinics in underserved areas and provide additional doses to these clinics;
- Ensure transportation is available for patients to access the clinics; and
- Partner with local agencies and community organizations to promote vaccine confidence.
Each of these components is necessary to ensure underserved communities and communities of color are interested in receiving vaccines and are able to access them.
States Begin to Incorporate Children into their COVID-19 Vaccine Distribution Plans
/in COVID-19 State Action Center Blogs, Featured News Home Children/Youth with Special Health Care Needs, Children/Youth with Special Health Care Needs, Chronic and Complex Populations, COVID-19, Health Equity, Immunization, Maternal, Child, and Adolescent Health, Population Health, Social Determinants of Health, Vaccines /by Olivia RandiTo date, there have been more than 2 million COVID-19 infections in US children and 8,000 pediatric hospitalizations. As states begin vaccinating those age 16 and older, many are drafting plans and applying lessons learned from their existing vaccination initiatives for the day when a vaccine is authorized for younger children.
As the Biden Administration rolls out its comprehensive plan to vaccinate 100 million American adults in the next 100 days and reopen schools in 100 days, states are already taking actions to include children in their vaccine distribution plans and tackling issues, such as:
- Should schools require students to get the COVID-19 vaccine, similar to other immunization requirements?
- How should they prioritize children with medical conditions or living in congregate settings that put them at higher risk of infection?
Background
Children are at lower risk of illness from COVID-19 than adults, yet this population can still develop symptoms and spread the virus to others. Though children have experienced fewer severe physical illness than adults, the pandemic has significantly impacted their emotional and social development. Children and their families have been stressed by social distancing, disruptions in schooling, unemployment, and loss of family members due to COVID-19.
Last October, states submitted COVID-19 vaccine distribution plans to the Centers for Disease Control and Prevention (CDC) that outlined their approaches, including how they will collaborate with stakeholders, enroll providers, and track vaccinations. The federal Advisory Committee on Immunization Practices (ACIP) has recommended vaccinations first for health care personnel and long-term care facility residents, people 65 and older, essential workers, and those with high-risk medial conditions. States are using these recommendations to guide their approaches to prioritizing populations for vaccine distribution.
ACIP is currently discussing vaccine trials in pediatric populations and has indicated it may update its recommendations once a vaccine is authorized for children under age 16. Meanwhile, several states have already identified a distribution phase for children in their current plans.
Youth age 12 and older have just begun enrolling in vaccine trials. If the vaccine is authorized for this age group, it will next be tested in a younger pediatric population. While there have been barriers to clinical trials for the vaccine in this population and the timeline is unclear, it will be months before any children under age 16 are eligible for vaccination. As states grapple with challenges in distributing the vaccine to currently eligible populations, they may be able to leverage the lessons they are now learning to improve distribution for younger children in the future.
Additionally, there are already systems in place to deliver vaccines to children, and many states plan to use the Vaccines for Children (VFC) infrastructure for enrolling and verifying providers, distributing, and tracking COVID-19 vaccine administration for all populations, including adults. States may find that these established protocols will facilitate vaccinating children.
States differ in how they have – or have not yet – included children in their vaccine distribution plans while the vaccine undergoes pediatric clinical trials. State approaches include:
- Incorporating child health agency representatives in COVID-19 vaccination planning teams;
- Designating roles for child health programs and providers to facilitate distribution; and
- Prioritizing children or subpopulations of children for when the vaccine is authorized.
Several states have indicated their pediatric vaccination plans may be updated once the vaccine is authorized for children. (See the table for a list of states that have included pediatric-specific approaches in their vaccine distribution plans.)
Including Child Health Stakeholders in Vaccination Planning
States have developed organizational structures that include internal and external agency representation to facilitate COVID-19 vaccination planning. At least 31 states have included child health stakeholders on their vaccine planning teams and advisory councils. These stakeholders include state chapters of the American Academy of Pediatrics (AAP) and other provider groups, children’s hospitals, other pediatric providers, state education agencies, local school districts, and others. Including these representatives in vaccine distribution planning early offers an important perspective for distributing the vaccine when it is authorized for children.
- Washington, DC’s vaccine planning team includes representatives from the District’s chapter of the American Academy of Pediatrics, pediatric providers, public schools, Families USA, and March of Dimes.
- Ohio’s vaccine planning team includes representatives from Ohio Children’s Hospital Association, Ohio Department of Education, and select local school districts.
Designating Roles for Child Health Programs and Providers
Beyond their vaccine planning teams, states have identified and partnered with child health programs and providers to support implementation of their distribution plans. These partners include pediatric practices, local school districts, and state public health agencies, including Title V Maternal and Child Health programs. Forming partnerships with these entities early in the planning process can facilitate rapid vaccine deployment once it is authorized. The specific roles designated to these partners include promoting the vaccine, facilitating communication with children and their families, identifying eligible children, and administering the vaccine.
- Connecticut has identified vaccine administration locations that will specifically serve children. These include school-based health centers and pediatric medical practices.
- North Carolina plans to partner with schools to help identify children for vaccination once it is authorized. The state is also engaged with the state’s AAP and the Pediatric Society to support education and communication about the vaccine.
Prioritizing Children Pending Authorization
Six states (GA, HI, ME, NC, OH, and RI), to date, have identified children as a priority population within Phase 3 of their vaccine distribution plans. During this phase, states anticipate having adequate supply of the vaccine to meet demand. At this point, it is expected that Phase 1 and 2 populations will largely have been vaccinated. Several states have also noted that they will update their vaccine distribution plans to include children when the vaccine is authorized for those under age 16, pending ACIP recommendations. States have also prioritized sub-populations of children, including those in congregate settings and those at higher risk of illness due to COVID-19.
Children and youth in congregate settings:
While children and youth are at a lower risk of illness from COVID-19, those residing in a congregate setting (e.g., residential treatment facilities) are at an increased risk of exposure and transmission, prompting some states to prioritize vaccination of children in youth-specific congregate settings in their distribution plans. Additionally, children and youth residing in congregate settings often have special needs and may have underlying conditions that increase their risk of symptoms due to COVID-19 in addition to their increased risk of exposure. Several states have included children in congregate settings in Phase 1 of their distribution plans. However, if the vaccine is not authorized for those under age 16 during Phase 1, these children would receive the vaccine during a later phase.
- Louisiana’s plan prioritizes residents of psychiatric residential treatment facilities and therapeutic group home facilities, which typically serve youth under age 21. Eligible youth in these facilities are in Phase 1B of the state’s vaccine distribution plan.
- New Mexico identifies residents at county juvenile justice centers and other congregate settings, including residential treatment centers, to receive a vaccine in the later part of Phase 1. The state also works with state agencies to identify critical populations, including youth in shelters, as part of its COVID-19 response.
States with Child-Related Provisions in their COVID-19 Vaccine Distribution Plans as of Jan. 6, 2021
| Child-related component* | States |
| Child health agencies included in vaccination planning teams | AL, AZ, AK, CO, DC, FL, GA, HI, ID, KS, LA, ME, MD, MA, MI, MT, NH, NV, NJ, NM, NY, NC, OH, OR, PA, RI, SC, UT, VA, WA, WY |
| Designated roles for child health programs and providers | CT, HI, LA, ME, NE, NJ, NC, OR, VT, WA |
| Prioritizes children for Phase 3** | GA, HI, ME, NC, OH, RI |
| Prioritizes children in congregate settings** | FL, LA, NM, OK, PA |
| Prioritizes children at higher COVID-19 risk** | HI, KY, ME, NY, OK |
| Specifies that the plan may be updated to include or reprioritize children** | CO, DC, IA, NV, NC |
| * The states listed here have included these provisions in their vaccine distribution plan as of Jan. 6, 2020. Other states may have taken or plan to take these actions, but they are not specified in their plans.
** Pending authorization of the vaccine for children and Advisory Committee on Immunization Practices (ACIP) recommendations. |
|
Children at higher risk of illness due to COVID-19: While the distribution phase differs, most states have categorized people with chronic conditions that increase their risk for illness due to COVID-19 as a priority group for vaccine receipt. Because most states do not specify the age range for this prioritized group in their distribution plans, some of these states may implicitly plan to include children, including children and youth with special health care needs (CYSHCN) who are at increased risk of COVID-19 illness, within this group when the vaccine is authorized for pediatric populations. However, five states (HI, KY, ME, NY, and OK) have specifically included children at higher risk as a prioritized population.
- Oklahoma has prioritized students including those in K-12 schools, childcare facilities, and early childhood facilities for Phase 3 of their vaccination distribution. Within their distribution plans, they specify that students at higher risk due to comorbid conditions will be prioritized among all students.
- Maine’s distribution plan specifies that “people of all ages” with conditions that put them at higher risk will be prioritized for earlier phases of vaccination. Anyone with a condition that puts them at significantly higher risk will be prioritized for Phase 1b, and those with conditions that put them at moderately high risk will be prioritized for Phase 2.
Key Considerations
As the vaccine is tested for safety in the pediatric population, states are considering how they will further incorporate children into their distribution plans if it is authorized.
- Including child health stakeholders in planning for the vaccine for children. Many states have leveraged the existing VFC infrastructure and partnered with child health agencies to support planning and implementation for distribution of the currently available vaccine. This important perspective will be increasingly critical if the vaccine is authorized for use in children. States can consider collaborating with additional stakeholders that represent the broad range of child health services to effectively support vaccine administration for the pediatric population.
- Leveraging lessons learned from distribution of the adult vaccine. States have faced various challenges in distributing the vaccine to those who are currently eligible. Given that children under age 16 will not be eligible for the vaccine for at least several months, states may be able to draw from their experiences to improve their strategies for distributing the vaccine to children while also considering the challenges and opportunities that are unique to the pediatric population.
- Prioritizing caregivers of children with underlying conditions. Many CYSHCN who may have underlying conditions that increase their susceptibility to COVID-19 symptoms are cared for by family members. To reduce the risk for CYSHCN, states can prioritize vaccinating these family members by classifying them as health care workers.
-
- Prioritizing sub-populations of children. Children who are at higher risk of COVID-19 due to underlying medical conditions and/or those in congregate facilities are important populations for states to consider for prioritization. Additionally, states can consider how to distribute the vaccine to minimize learning losses due to school closures. CYSHCN may face unique challenges in accessing virtual learning compared to other children, whether or not they are at greater risk of COVID-19 illness. This is particularly true for children of color, those with high socioeconomic needs, and those with limited access to technology. Prioritizing children with greater virtual learning challenges could more equitably facilitate a safe return to in-person learning.
- Determining whether the vaccine will be a school requirement. Several state vaccine distribution plans include language about their state statutes that currently require certain vaccines for children to enter schools. While these plans do not specify that the COVID-19 vaccine is a school requirement, this will be an important consideration for states if the vaccine is authorized for use in pediatric populations.
- Distributing the vaccine across pediatric age groups. Vaccination authorization in children will likely be authorized in stages, with current trials for those ages 12 and older, and subsequent trials for younger age groups. This may impact states’ decisions governing how they prioritize vaccine distribution, when and which schools reopen for in-person instruction, and who, if anyone, is required to have received the vaccine to attend school in person.
The National Academy for State Health Policy will continue to monitor states’ COVID-19 vaccine distribution plans, and how states’ plans change once the vaccine is authorized for children under age 16.
Acknowledgements: This blog was supported by the Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) as part of a financial assistance award under the National Organizations of State and Local Officials co-operative agreement. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement, by HRSA/HHS, or the US government.
Sign Up for Our Weekly Newsletter
Sign Up for Our Weekly Newsletter
Washington, DC Office:
1233 20th St., N.W., Suite 303Washington, DC 20036
p: (202) 903-0101
f: (202) 903-2790
Contact Us
Phone: 202-903-0101

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































